PETS PetMed Express, Inc. - Common Stock
NASDAQ · Retail · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026PETS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
PETS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über PetMed Express, Inc. - Common Stock Unternehmensübersicht von Wikipedia
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Business model
PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.
History
Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.
Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.
Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.
In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.
In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.
In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.
As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.
In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.
In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.
Recognition
The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.
== References ==
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PETS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.05-Jahres-Durchschnitt ≈9.3 | ≈9.3 | · | · | |
| P/S (TTM) | 0.25-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.2 | Fairer Wert | |
| K/B (MRQ) | 1.35-Jahres-Durchschnitt ≈1.2 | ≈1.2 | · | · | |
| Kurs / FCF (TTM) | -1.15-Jahres-Durchschnitt ≈-247.6 | ≈-247.6 | · | · | |
| Kurs / Cashflow (TTM) | -1.25-Jahres-Durchschnitt ≈13.4 | ≈13.4 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 1.75-Jahres-Durchschnitt ≈2.2 | ≈2.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PETS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 27.9%5-Jahres-Durchschnitt ≈28.5% | ≈28.5% | 36.4% | Schwach | |
| Betriebsgewinnmarge (TTM) | -18.2%5-Jahres-Durchschnitt ≈-8.5% | ≈-8.5% | -1.3% | Schwach | |
| EBITDA-Marge (TTM) | -12.7%5-Jahres-Durchschnitt ≈-5.8% | ≈-5.8% | -1.3% | Schwach | |
| Vorgewinnmarge (TTM) | -17.4%5-Jahres-Durchschnitt ≈-7.9% | ≈-7.9% | -2.0% | Schwach | |
| Nettogewinnmarge (TTM) | -17.3%5-Jahres-Durchschnitt ≈-8.9% | ≈-8.9% | -2.0% | Schwach | |
| ROA (TTM) | -33.7%5-Jahres-Durchschnitt ≈-19.4% | ≈-19.4% | -13.0% | Schwach | |
| ROE (TTM) | -78.6%5-Jahres-Durchschnitt ≈-38.2% | ≈-38.2% | 12.9% | Schwach | |
| ROIC | -202.5%5-Jahres-Durchschnitt ≈-77.2% | ≈-77.2% | -31.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PETS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 0.75-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 1.3 | Geringe Liquidität | |
| Quick Ratio | 0.45-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.3 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | PETS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -21.1%5-Jahres-Durchschnitt ≈-9.2% | ≈-9.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -10.2%5-Jahres-Durchschnitt ≈-6.5% | ≈-6.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -10.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | PETS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.65-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 1.5 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 84.75-Jahres-Durchschnitt ≈92.6 | ≈92.6 | 84.7 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$947.2K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Aug 11, 2023 | $0,30 | USD | ≈9.4% |
| Jun 5, 2023 | $0,30 | USD | ≈8.2% |
| Feb 16, 2023 | $0,30 | USD | ≈6.1% |
| Nov 17, 2022 | $0,30 | USD | ≈6.3% |
| Aug 11, 2022 | $0,30 | USD | ≈5.4% |
| Mai 19, 2022 | $0,30 | USD | ≈5.9% |
| Feb 4, 2022 | $0,30 | USD | ≈5.0% |
| Nov 5, 2021 | $0,30 | USD | ≈3.8% |
| Aug 5, 2021 | $0,30 | USD | ≈4.0% |
| Mai 13, 2021 | $0,30 | USD | ≈4.1% |
| Jan 29, 2021 | $0,28 | USD | ≈2.9% |
| Nov 6, 2020 | $0,28 | USD | ≈3.7% |
| Jul 30, 2020 | $0,28 | USD | ≈3.5% |
| Mai 14, 2020 | $0,28 | USD | ≈3.4% |
| Jan 31, 2020 | $0,27 | USD | ≈4.3% |
| Nov 1, 2019 | $0,27 | USD | ≈4.7% |
| Aug 1, 2019 | $0,27 | USD | ≈6.7% |
| Mai 16, 2019 | $0,27 | USD | ≈5.5% |
| Feb 1, 2019 | $0,27 | USD | ≈4.6% |
| Nov 2, 2018 | $0,27 | USD | ≈3.7% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 31. März 2027 | Aug 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31. Dezember 2026 | Jun 2, 2026 | $-0.19 | $-0.18 | -3.5% |
| 30. Juni 2026 | Aug 13, 2026 | $-0.28 | $0.12 | -328.8% |
| 31. März 2026 | $-0.19 | $-0.18 | -3.5% | |
| 31. Dezember 2025 | $-0.50 | $-0.06 | -717.0% | |
| 30. Juni 2025 | $-1.65 | $-0.07 | -2210.9% | |
| 31. März 2025 | $-0.56 | $-0.05 | -1129.2% | |
| 31. Dezember 2024 | $-0.03 | $-0.01 | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | · | |
| Cost of Revenue | · | $158M | $189M | $171M | $195M | $219M | $203M | $188M | $176M | $170M | $158M | · | |
| Gross Profit | $50M | $69M | $85M | $77M | $77M | $84M | $81M | $95M | $98M | $79M | $76M | · | |
| SG&A Expense | $51M | $39M | $55M | $42M | $31M | $30M | $25M | $25M | $24M | $23M | $21M | · | |
| Operating Expenses | $109M | $71M | $93M | $70M | $53M | $54M | $50M | $49M | $46M | $42M | $44M | · | |
| Operating Income | $-59M | $-2M | $-8M | $6M | $24M | $31M | $31M | $46M | $52M | $37M | $32M | · | |
| Interest Income | · | · | · | $2M | $335.0K | $314.0K | $2M | $2M | $658.0K | $141.0K | $190.0K | · | |
| Other Non-op | $803.0K | $758.0K | $1M | $944.0K | $1M | $1M | $1M | $1M | $995.0K | $300.0K | $63.0K | · | |
| Pretax Income | $-57M | $-587.0K | $-6M | $7M | $24M | $31M | $34M | $49M | $54M | $38M | $33M | · | |
| Income Tax | $-73.0K | $6M | $1M | $2M | $5M | $7M | $8M | $11M | $17M | $14M | $12M | · | |
| Net Income | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | · | |
| EPS (Basic) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | · | |
| EPS (Diluted) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | · | |
| Shares (Basic) | 20,921,361 | 20,596,022 | 20,395,959 | 20,274,786 | 20,175,930 | 20,060,000 | 20,041,000 | 20,461,000 | 20,346,000 | 20,232,000 | 20,124,000 | · | |
| Shares (Diluted) | 20,921,361 | 20,596,022 | 20,395,959 | 20,339,002 | 20,357,820 | 20,119,000 | 20,055,000 | 20,491,000 | 20,433,000 | 20,378,000 | 20,254,000 | · | |
| EBITDA | $-49M | $6M | $-1M | $6M | $26M | $38M | $31M | $46M | $52M | · | · | · |
Bilanz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $55M | $55M | $104M | $111M | $119M | $104M | $101M | $78M | $59M | $38M | $36M | |
| Receivables | $2M | $2M | $3M | $2M | $2M | $3M | $4M | $3M | $2M | $2M | · | · | |
| Inventory | $14M | $16M | $29M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $5M | $6M | $5M | $5M | $5M | $4M | $1M | $882.0K | $1M | · | · | |
| Current Assets | $44M | $79M | $94M | $130M | $151M | $161M | $129M | $126M | $105M | $82M | · | · | |
| PP&E (Net) | $26M | $29M | $27M | $26M | $24M | $25M | $25M | $27M | $29M | $30M | · | · | |
| PP&E (Gross) | $58M | $54M | $47M | $41M | $36M | $36M | $36M | $36M | $35M | $34M | · | · | |
| Accum. Depreciation | $32M | $25M | $20M | $15M | $12M | $10M | $11M | $8M | $6M | $4M | · | · | |
| Goodwill | $0 | $27M | $27M | $0 | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $8M | $11M | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | $860.0K | · | · | |
| Total Assets | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Accounts Payable | $21M | $24M | $37M | $25M | $28M | $40M | $20M | $16M | $15M | $15M | · | · | |
| Current Liabilities | $52M | $63M | $72M | $58M | $56M | $45M | $24M | $19M | $18M | $18M | · | · | |
| Capital Leases | $42.0K | $535.0K | $995.0K | $0 | · | · | · | · | · | · | · | · | |
| Deferred Tax | $175.0K | $263.0K | $0 | $3M | $0 | $1M | $970.0K | $1M | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $52M | $64M | $73M | $58M | $56M | $46M | $25M | $20M | $19M | $19M | · | · | |
| Common Stock | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | $21.0K | $21.0K | $21.0K | · | · | |
| Paid-in Capital | $20M | $19M | $25M | $18M | $12M | $7M | $4M | $12M | $9M | $7M | · | · | |
| Retained Earnings | $9M | $67M | $72M | $92M | $112M | $134M | $126M | $122M | $106M | $87M | · | · | |
| Stockholders' Equity | $29M | $85M | $97M | $110M | $123M | $125M | $120M | $135M | $116M | $93M | $83M | $75M | |
| Liabilities + Equity | $81M | $149M | $170M | $167M | $180M | $187M | $155M | $154M | $135M | $113M | · | · | |
| Shares Outstanding | 21,385,638 | 20,657,000 | 21,148,000 | 21,084,000 | 20,979,000 | 20,269,000 | 20,166,000 | 20,674,000 | 20,601,000 | 20,526,000 | · | · |
Cashflow
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $7M | $4M | $3M | · | · | · | · | · | · | · | |
| Stock-based Comp | $1M | $-7M | $7M | $7M | $5M | $3M | $3M | $3M | $3M | $2M | $2M | · | |
| Deferred Tax | $-88.0K | $5M | $292.0K | $-2M | $-846.0K | $-1M | $-151.0K | $125.0K | $-92.0K | $2M | $-23.0K | · | |
| Amort. of Intangibles | $2M | $2M | $2M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $18M | $5M | $-2M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-28M | $5M | $4M | $28M | $18M | $40M | $39M | $45M | $37M | $47M | $21M | · | |
| CapEx | $5M | $5M | $5M | $5M | $2M | $2M | $2M | $620.0K | $703.0K | $11M | $20M | · | |
| Investing Cash Flow | $-5M | $-5M | $-41M | $-10M | $-2M | $-2M | $-2M | $-620.0K | $-703.0K | $-11M | $-4M | · | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $11M | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $-11M | · | · | · | · | · | |
| Dividends Paid | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · | |
| Financing Cash Flow | $-299.0K | $-181.0K | $-12M | $-25M | $-24M | $-23M | $-33M | $-22M | $-17M | $-16M | $-15M | · | |
| Net Change in Cash | $-33M | $-576.0K | $-49M | $-7M | $-8M | $15M | $3M | $23M | $19M | $21M | $2M | · | |
| Taxes Paid | $52.0K | $525.0K | $130.0K | $4M | $6M | $10M | · | · | · | · | · | · | |
| Free Cash Flow | $-33M | $-395.0K | $-194.0K | $23M | $17M | $38M | $37M | $45M | $37M | · | · | · |
Rentabilität
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.1% | 30.5% | 28.0% | 27.6% | 28.6% | 29.1% | · | · | 35.7% | · | · | · | |
| Operating Margin | -32.8% | -0.67% | -2.9% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| Net Margin | -32.0% | -2.8% | -2.7% | 2.0% | 7.7% | 9.9% | · | · | 13.6% | · | · | · | |
| Pretax Margin | -32.0% | -0.26% | -2.2% | 2.9% | 9.9% | 12.7% | · | · | 19.7% | · | · | · | |
| EBITDA Margin | -27.5% | 2.4% | -0.39% | 2.4% | 9.4% | 12.2% | · | · | 19.0% | · | · | · | |
| ROA | -49.8% | -3.9% | -4.4% | · | 11.6% | 17.8% | 16.7% | 26.1% | 30.1% | · | · | · | |
| ROE | -100.4% | -6.9% | -7.2% | · | 15.8% | 23.4% | 19.5% | 30.1% | 35.7% | · | · | · | |
| ROIC | -202.5% | -19.2% | -10.0% | · | 14.1% | 20.8% | 18.2% | 26.3% | 31.2% | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.3 | 1.3 | · | 4.5 | 3.6 | 5.3 | 6.8 | 5.8 | · | · | · | |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | 3.4 | 2.7 | 4.4 | 5.5 | 4.4 | · | · | · |
Effizienz
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.4 | 1.7 | · | 1.5 | 1.8 | · | · | 2.2 | · | · | · | |
| Inventory Turnover | · | 7.1 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 84.7 | 81.1 | 111.9 | · | 121.5 | 96.2 | · | · | 133.6 | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.35 | $4.12 | $4.57 | · | $6.78 | $6.97 | $6.45 | $6.51 | $5.62 | · | · | · | |
| Revenue / Share | $8.56 | $11.02 | $13.78 | $12.62 | $13.43 | $15.37 | · | · | $13.40 | · | · | · | |
| Cash Flow / Share | $-1.36 | $0.23 | $0.21 | $1.37 | $0.91 | $1.99 | $1.94 | $2.20 | $1.83 | · | · | · | |
| Cash / Share | $1.00 | $2.65 | $2.61 | · | $5.29 | $5.86 | $5.15 | $4.86 | $3.78 | · | · | · | |
| Dividend / Share | $0.00 | $0.00 | $0.60 | $1.20 | $1.20 | $1.12 | $1.08 | $1.06 | $0.85 | $0.76 | $0.72 | · | |
| EPS (TTM) | $-2.74 | $-0.30 | $-0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | $0.80 |
Wachstumsraten
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -21.1% | -17.2% | 10.7% | -9.1% | -10.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -10.2% | -5.9% | -3.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -72.8% | -22.7% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -72.5% | -21.8% | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -75.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $179M | $227M | $274M | $248M | $272M | $304M | $284M | $283M | $274M | $249M | $235M | $227M | |
| Net Income TTM | $-57M | $-6M | $-7M | $5M | $19M | $24M | $26M | $38M | $37M | $24M | $21M | $17M | |
| Market Cap | $49M | $87M | $101M | · | $541M | $713M | $580M | $471M | $860M | · | · | · | |
| P/E | -0.8 | -14.0 | -12.9 | 65.0 | 28.0 | 29.6 | 22.3 | 12.4 | 22.9 | 17.2 | 17.6 | 20.6 | |
| P/S | 0.3 | 0.4 | 0.4 | · | 2.0 | 2.3 | 2.0 | 1.7 | 3.1 | · | · | · | |
| P/B | 1.7 | 1.0 | 1.0 | · | 3.8 | 5.0 | 4.5 | 3.5 | 7.4 | · | · | · | |
| P / Tangible Book | 2.1 | 1.7 | 1.7 | 3.1 | 4.4 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.7 | 18.3 | 23.5 | · | 29.3 | 17.8 | 14.9 | 10.4 | 23.0 | · | · | · | |
| P / FCF | -1.5 | -219.1 | -522.2 | · | 32.3 | 18.9 | 15.9 | 10.6 | 23.5 | · | · | · | |
| Dividend Yield | 0.04% | 0.21% | 12.3% | · | 4.5% | 3.2% | 3.8% | 4.7% | 2.0% | · | · | · | |
| Earnings Yield | -120.2% | -7.2% | -7.7% | 1.5% | 3.6% | 3.4% | 4.5% | 8.1% | 4.4% | 5.8% | 5.7% | 4.8% | |
| Payout Ratio | -0.04% | -2.9% | -166.6% | 477.4% | 115.6% | 74.1% | 84.3% | 58.1% | 46.9% | · | · | · | |
| Annual Payout | $21.0K | $181.0K | $12M | $25M | $24M | $23M | $22M | $22M | $17M | $16M | $15M | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $43M | $41M | $44M | $51M | $51M | $52M | $58M | $66M | $60M | $64M | $69M | $76M | $53M | $57M | $63M | |
| Cost of Revenue | $30M | · | · | $32M | $37M | $36M | $36M | $39M | $47M | $35M | $44M | $48M | $51M | $30M | $41M | $43M | |
| Gross Profit | $11M | $14M | $9M | $12M | $14M | $15M | $16M | $19M | $19M | $24M | $19M | $21M | $25M | $23M | $17M | $20M | |
| SG&A Expense | $11M | $11M | $12M | $14M | $13M | $12M | $11M | $10M | $5M | $14M | $13M | $12M | $16M | $12M | $10M | $10M | |
| Operating Expenses | $18M | $20M | $20M | $21M | $49M | $21M | $17M | $18M | $15M | $28M | $22M | $20M | $27M | $23M | $17M | $17M | |
| Operating Income | $-6M | $-6M | $-10M | $-8M | $-34M | $-6M | $-450.0K | $554.0K | $4M | $-4M | $-3M | $875.0K | $-2M | $-212.0K | $-769.0K | $4M | |
| Interest Income | $100.0K | · | $200.0K | · | $300.0K | · | $500.0K | · | · | · | · | $570.0K | $620.0K | · | $708.0K | $388.0K | |
| Other Non-op | $438.0K | $273.0K | $148.0K | $195.0K | $187.0K | $161.0K | $180.0K | $186.0K | $231.0K | $325.0K | $293.0K | $254.0K | $506.0K | $226.0K | $259.0K | $261.0K | |
| Pretax Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-6M | $-242.0K | $925.0K | $5M | $-3M | $-3M | $1M | $-1M | $453.0K | $-211.0K | $4M | |
| Income Tax | $13.0K | $-102.0K | $11.0K | $9.0K | $9.0K | $6M | $465.0K | $-1M | $958.0K | $2M | $-618.0K | $565.0K | $-292.0K | $669.0K | $1.0K | $1M | |
| Net Income | $-6M | $-4M | $-11M | $-9M | $-34M | $-12M | $-707.0K | $2M | $4M | $-5M | $-2M | $715.0K | $-1M | $-216.0K | $-212.0K | $3M | |
| EPS (Basic) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.25 | $-0.10 | $0.04 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| EPS (Diluted) | $-0.28 | $-0.18 | $-0.50 | $-0.41 | $-1.65 | $-0.56 | $-0.03 | $0.11 | $0.18 | $-0.24 | $-0.10 | $0.03 | $-0.06 | $-0.01 | $-0.01 | $0.14 | |
| Shares (Basic) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,597,807 | 20,513,281 | · | 20,425,282 | 20,382,979 | 20,332,526 | · | 20,301,384 | 20,261,114 | |
| Shares (Diluted) | 21,682,381 | · | 21,008,521 | 20,889,124 | 20,755,416 | · | 20,634,651 | 20,938,817 | 20,941,505 | · | 20,425,282 | 20,780,455 | 20,332,526 | · | 20,301,384 | 20,343,980 | |
| EBITDA | $-4M | · | $-8M | $-6M | $-32M | · | $1M | $2M | $6M | · | $-1M | $3M | $-450.0K | · | $-769.0K | $3M |
Bilanz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $21M | $27M | $36M | $41M | $55M | $50M | $52M | $46M | $55M | $49M | $53M | $62M | · | $102M | $97M | |
| Receivables | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | · | $2M | $2M | |
| Inventory | $8M | $14M | $12M | $15M | $18M | $16M | $12M | $13M | · | $29M | · | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $8M | $6M | $6M | $5M | $4M | $4M | $4M | $6M | $9M | $10M | $9M | · | $6M | $5M | |
| Current Assets | $28M | $44M | $49M | $59M | $68M | $79M | $68M | $71M | $78M | $94M | $96M | $85M | $105M | · | $134M | $138M | |
| PP&E (Net) | $25M | $26M | $28M | $28M | $29M | $29M | $28M | $26M | $26M | $27M | $27M | $27M | $27M | · | $25M | $25M | |
| PP&E (Gross) | · | $58M | · | · | · | $54M | · | · | · | $47M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $32M | · | · | · | $25M | · | · | · | $20M | · | · | · | · | · | · | |
| Goodwill | · | $0 | $0 | $0 | $0 | $27M | $27M | $27M | $27M | $27M | $27M | $27M | $27M | · | · | · | |
| Intangibles | $5M | $5M | $6M | $6M | $7M | $8M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | · | · | · | |
| Total Assets | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Accounts Payable | $12M | $21M | $20M | $19M | $20M | $24M | $11M | $17M | $24M | $37M | $39M | $25M | $40M | · | $24M | $24M | |
| Current Liabilities | $41M | $52M | $55M | $57M | $58M | $63M | $48M | $49M | $58M | $72M | $72M | $61M | $79M | · | $31M | $31M | |
| Capital Leases | $0 | $42.0K | $167.0K | $291.0K | $414.0K | $535.0K | $652.0K | $768.0K | $883.0K | $995.0K | $890.0K | $1M | $1M | · | · | · | |
| Deferred Tax | $175.0K | $175.0K | $263.0K | $263.0K | $263.0K | $263.0K | · | · | · | $0 | · | · | $0 | · | $465.0K | $547.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | · | · | · | |
| Total Liabilities | $41M | $52M | $55M | $57M | $58M | $64M | $49M | $50M | $59M | $73M | $73M | $62M | $80M | · | $32M | $31M | |
| Common Stock | $22.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | $21.0K | · | $21.0K | $21.0K | |
| Paid-in Capital | $20M | $20M | $19M | $19M | $19M | $19M | $18M | $18M | $17M | $25M | $23M | $22M | $20M | · | $17M | $15M | |
| Retained Earnings | $3M | $9M | $13M | $24M | $32M | $67M | $78M | $79M | $77M | $72M | $77M | $79M | $84M | · | $117M | $123M | |
| Stockholders' Equity | $23M | $29M | $33M | $43M | $52M | $85M | $96M | $96M | $94M | $97M | $100M | $100M | $104M | $110M | $134M | $138M | |
| Liabilities + Equity | $64M | $81M | $88M | $100M | $110M | $149M | $145M | $146M | $153M | $170M | $173M | $163M | $184M | · | $165M | $169M | |
| Shares Outstanding | 21,682,381 | 21,385,638 | 21,382,521 | 21,015,559 | 20,835,210 | 20,656,822 | 20,656,457 | 20,663,218 | 20,600,652 | 21,148,000 | 21,160,739 | 21,147,006 | 21,170,000 | 21,084,000 | 21,077,000 | 21,077,000 |
Cashflow
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $994.0K | $941.0K | $858.0K | |
| Stock-based Comp | $198.0K | $274.0K | $300.0K | $200.0K | $591.0K | $518.0K | $500.0K | $600.0K | $-8M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Deferred Tax | · | $-88.0K | $0 | $0 | $0 | $5M | $465.0K | $-670.0K | $-26.0K | $728.0K | $-355.0K | $304.0K | $-627.0K | $-516.0K | $-725.0K | $-521.0K | |
| Amort. of Intangibles | $200.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $0 | $0 | $0 | |
| Other Non-cash | $-4M | · | · | · | $19M | · | · | · | $-6M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-8M | $-5M | $-9M | $-2M | $-12M | $7M | $-1M | $7M | $-9M | $7M | $-3M | $-777.0K | $562.0K | $10M | $13M | $-1M | |
| CapEx | $641.0K | $720.0K | $-21.0K | $3M | $1M | $2M | $777.0K | $1M | $683.0K | $1M | $1M | $984.0K | $1M | $2M | $993.0K | $1M | |
| Investing Cash Flow | $-641.0K | $-720.0K | $21.0K | $-3M | $-1M | $-2M | $-777.0K | $-1M | $-683.0K | $-1M | $-1M | $-984.0K | $-37M | $-2M | $-993.0K | $-1M | |
| Dividends Paid | $0 | $-3.0K | $1.0K | $22.0K | $1.0K | $5.0K | $1.0K | $71.0K | $104.0K | $18.0K | $15.0K | $6M | $6M | $6M | $6M | $6M | |
| Financing Cash Flow | $-5.0K | $-38.0K | $0 | $-231.0K | $-30.0K | $-5.0K | $-1.0K | $-71.0K | $-104.0K | $-18.0K | $-15.0K | $-6M | $-6M | $-6M | $-6M | $-6M | |
| Net Change in Cash | $-8M | $-6M | $-9M | $-5M | $-14M | $5M | $-2M | $6M | $-9M | $6M | $-4M | $-8M | $-43M | $2M | $6M | $-9M | |
| Taxes Paid | $-120.0K | $-22.0K | $8.0K | $70.0K | $-4.0K | $51.0K | $8.0K | $385.0K | $81.0K | $87.0K | $43.0K | $0 | $0 | $442.0K | $1M | · | |
| Free Cash Flow | $-8M | · | · | · | $-14M | · | · | · | $-9M | · | · | · | $-591.0K | · | · | · |
Rentabilität
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.6% | · | 23.3% | 28.0% | 28.1% | · | 28.1% | 29.1% | 26.5% | · | 27.4% | 28.3% | 28.8% | · | 25.9% | 28.2% | |
| Operating Margin | -15.2% | · | -25.8% | -18.9% | -66.7% | · | -0.85% | 0.93% | 6.5% | · | -4.7% | 1.2% | -2.7% | · | -1.3% | 4.5% | |
| Net Margin | -15.0% | · | -25.9% | -19.2% | -66.7% | · | -1.3% | 3.9% | 5.5% | · | -3.1% | 1.0% | -1.5% | · | -0.03% | 3.9% | |
| Pretax Margin | -14.9% | · | -25.9% | -19.2% | -66.7% | · | -0.46% | 1.6% | 6.9% | · | -4.0% | 1.8% | -1.8% | · | 0.34% | 5.5% | |
| EBITDA Margin | -10.0% | · | -19.9% | -13.8% | -62.2% | · | 2.1% | 3.7% | 9.0% | · | -2.0% | 3.6% | -0.58% | · | -1.3% | 4.5% | |
| ROA | -7.1% | · | -9.1% | -6.9% | -26.0% | · | -0.44% | 1.5% | 2.2% | · | -1.2% | 0.43% | -0.65% | · | -0.01% | 1.6% | |
| ROE | -16.5% | · | -16.4% | -12.2% | -47.1% | · | -0.72% | 2.4% | 3.8% | · | -1.7% | 0.60% | -0.93% | · | -0.01% | 1.8% | |
| ROIC | -27.2% | · | -32.0% | -19.5% | -66.2% | · | -1.4% | 1.4% | 3.7% | · | -2.4% | 0.49% | -1.6% | · | 0.06% | 1.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | · | 0.9 | 1.0 | 1.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | 1.4 | 1.3 | · | 4.3 | 4.5 | |
| Quick Ratio | 0.4 | · | 0.5 | 0.7 | 0.7 | · | 1.1 | 1.1 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 3.4 | 3.2 |
Effizienz
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.3 | 0.4 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Inventory Turnover | 2.2 | · | · | 2.3 | 4.0 | · | 6.5 | 6.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 24.8 | · | 21.3 | 24.7 | 26.5 | · | 25.3 | 31.4 | 32.7 | · | 33.7 | 37.7 | 42.6 | · | 36.7 | 38.0 |
Pro Aktie
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.06 | · | $1.53 | $2.05 | $2.47 | · | $4.66 | $4.67 | $4.54 | · | $4.73 | $4.75 | $4.92 | · | $6.34 | $6.55 | |
| Revenue / Share | $1.89 | · | $1.94 | $2.12 | $2.47 | · | $2.57 | $2.85 | $3.24 | · | $3.20 | $3.42 | $3.85 | · | $2.90 | $3.21 | |
| Cash Flow / Share | $-0.35 | · | · | · | $-0.59 | · | · | · | $-0.41 | · | · | · | $0.03 | · | · | · | |
| Cash / Share | $0.60 | · | $1.26 | $1.72 | $1.97 | · | $2.43 | $2.52 | $2.23 | · | $2.34 | $2.53 | $2.91 | · | $4.86 | $4.58 | |
| Dividend / Share | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.30 | $0.30 | $0.30 | $0.30 | $0.30 | |
| EPS (TTM) | $-1.37 | · | $-3.12 | $-2.65 | $-2.13 | · | $0.02 | $-0.05 | $-0.13 | · | $-0.14 | $-0.05 | $0.06 | · | $0.44 | $0.66 |
Bewertung (TTM)
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $169M | · | $187M | $198M | $212M | · | $236M | $247M | $259M | · | $262M | $256M | $250M | · | $253M | $256M | |
| Net Income TTM | $-29M | · | $-65M | $-55M | $-44M | · | $357.0K | $-963.0K | $-3M | · | $-3M | $-849.0K | $1M | · | $9M | $13M | |
| Market Cap | $42M | · | $68M | $53M | $69M | · | $100M | $76M | $83M | · | $160M | $217M | $292M | · | $373M | $411M | |
| P/E | -1.4 | · | -1.0 | -0.9 | -1.6 | · | 241.0 | -73.6 | -31.2 | · | -54.0 | -205.0 | 229.8 | · | 40.2 | 29.6 | |
| P/S | 0.2 | · | 0.4 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.6 | 0.8 | 1.2 | · | 1.5 | 1.6 | |
| P/B | 1.8 | · | 2.1 | 1.2 | 1.3 | · | 1.0 | 0.8 | 0.9 | · | 1.6 | 2.2 | 2.8 | · | 2.8 | 3.0 | |
| P / Tangible Book | 2.3 | · | 2.6 | 1.4 | 1.6 | · | 1.7 | 1.3 | 1.5 | · | 2.6 | 3.5 | 4.5 | · | 2.8 | 3.0 | |
| P / Cash Flow | -5.4 | · | · | · | -5.6 | · | · | · | -9.8 | · | · | · | 519.5 | · | · | · | |
| Dividend Yield | 0.05% | · | 0.04% | 0.05% | 0.11% | · | 0.19% | 0.27% | 7.8% | · | 11.8% | 11.5% | 8.5% | · | 6.6% | 5.9% | |
| Earnings Yield | -71.4% | · | -97.5% | -105.6% | -64.2% | · | 0.41% | -1.4% | -3.2% | · | -1.8% | -0.49% | 0.44% | · | 2.5% | 3.4% | |
| Payout Ratio | 0.00% | · | · | · | 0.00% | · | · | · | 2.8% | · | · | · | -537.1% | · | · | · | |
| Annual Payout | $20.0K | · | $29.0K | $29.0K | $78.0K | · | $194.0K | $208.0K | $6M | · | $19M | $25M | $25M | · | $24M | $24M |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Umsatz | $179M | $227M | $274M | $248M | · |
| Bruttogewinnmarge % | 28.1% | 30.5% | 28.0% | 27.6% | · |
| Betriebsgewinnmarge % | -32.8% | -0.67% | -2.9% | 2.4% | · |
| Nettoergebnis | $-57M | $-6M | $-7M | $5M | · |
| Verwässerte EPS | $-2.74 | $-0.30 | $-0.37 | $0.25 | · |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 0.8 | 1.3 | 1.3 | · | · |
| Quick Ratio | 0.4 | 0.9 | 0.8 | · | · |
| Kennzahl | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-33M | $-395.0K | $-194.0K | $23M | · |
Institutionelle Eigentümer (13F) 53 Einreicher · $11.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 10 (0 vs. Vorquartal) | 8 (-2 vs. Vorquartal) | 9 (-1 vs. Vorquartal) | 18 (+2 vs. Vorquartal) | -1.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.084.028 | 963.759 | 26,00% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.171.962 | 1.131.230 | 18,31% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.588.602 | 827.397 | 13,39% | Aktien |
| BlackRock, Inc. | $1.091.050 | 568.255 | 9,20% | Aktien |
| FEDERATED HERMES, INC. | $407.367 | 212.170 | 3,43% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $391.947 | 204.075 | 3,30% | Aktien |
| STEEL PARTNERS HOLDINGS L.P. | $371.835 | 193.664 | 3,13% | Aktien |
| UBS Group AG | $265.594 | 138.330 | 2,24% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232.412 | 121.048 | 1,96% | Aktien |
| Rangeley Capital, LLC | $232.320 | 121.000 | 1,96% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $212.124 | 110.481 | 1,79% | Aktien |
| STATE STREET CORP | $201.932 | 105.173 | 1,70% | Aktien |
| Formidable Asset Management, LLC | $195.056 | 85.551 | 1,64% | Aktien |
| Empowered Funds, LLC | $158.108 | 82.348 | 1,33% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $156.301 | 81.407 | 1,32% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $152.646 | 79.503 | 1,29% | Aktien |
| CITADEL ADVISORS LLC | $142.324 | 74.127 | 1,20% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $115.811 | 60.353 | 0,98% | Aktien |
| UMB Bank, n.a. | $115.200 | 60.000 | 0,97% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $91.647 | 47.733 | 0,77% | Aktien |
| NORTHERN TRUST CORP | $81.893 | 42.653 | 0,69% | Aktien |
| XTX Topco Ltd | $80.511 | 41.933 | 0,68% | Aktien |
| CIBC Private Wealth Group LLC | $75.300 | 30.000 | 0,63% | Aktien |
| SIMPLEX TRADING, LLC | $47.702 | 24.845 | 0,40% | Aktien |
| IMC-Chicago, LLC | $44.014 | 22.924 | 0,37% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $29.568 | 15.400 | 0,25% | Kaufoption |
| Jain Global LLC | $26.148 | 13.619 | 0,22% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $24.712 | 12.871 | 0,21% | Aktien |
| MORGAN STANLEY | $22.282 | 11.604 | 0,19% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $17.637 | 9.186 | 0,15% | Aktien |
| Vanguard Global Advisers, LLC | $15.590 | 8.120 | 0,13% | Aktien |
| OSAIC HOLDINGS, INC. | $6.772 | 3.527 | 0,06% | Aktien |
| SBI Securities Co., Ltd. | $2.148 | 1.119 | 0,02% | Aktien |
| Bank & Trust Co | $2.054 | 901 | 0,02% | Aktien |
| HARBOUR INVESTMENTS, INC. | $1.037 | 540 | 0,01% | Aktien |
| Accredited Wealth Management, LLC | $1.004 | 5.636 | 0,01% | Aktien |
| Allworth Financial LP | $949 | 494 | 0,01% | Aktien |
| MCF Advisors LLC | $768 | 400 | 0,01% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $730 | 415 | 0,01% | Aktien |
| Ascentis Independent Advisors | $683 | 356 | 0,01% | Aktien |
| WELLS FARGO & COMPANY/MN | $577 | 300 | 0,00% | Aktien |
| ROTHSCHILD INVESTMENT LLC | $480 | 250 | 0,00% | Aktien |
| Tower Research Capital LLC (TRC) | $323 | 168 | 0,00% | Aktien |
| Farther Finance Advisors, LLC | $290 | 151 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $250 | 129.933 | 0,00% | Aktien |
| FMR LLC | $115 | 60 | 0,00% | Aktien |
| Elevated Capital Advisors, LLC | $96 | 50 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $23 | 12 | 0,00% | Aktien |
| CITIGROUP INC | $17 | 9 | 0,00% | Aktien |
| CoreCap Advisors, LLC | $8 | 4 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| SilverCape Investments Limited, Peter Kennedy ×3 Einreichungen | 29. Juni 2026 | 12,07% | Änderung | Passive Anlage | SEC |
| Diveroli Investment Group LLC, Kingbird Ventures LLC | 11. Februar 2026 | 1,83% | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 29 Insider · 8 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jeffrey Allen Willard | CEO and President | 28. September 2026 A | 250.000 | 0 | 0 | $0 |
| Leslie C.G. Campbell | Interim CEO and President | 11. August 2026 A | 145.000 | 0 | 0 | $0 |
| Sandra Yvette Campos | CEO & President | 30. April 2025 S | 578.524 | 0 | 0 | $0 |
| Menderes Akdag | CEO & President | 27. Januar 2021 S | 337.800 | 0 | 0 | $0 |
| Douglas Krulik | CAO and Interim CFO | 26. Juni 2026 A | 102.500 | 0 | 0 | $0 |
| Robyn M. D'Elia | Chief Financial Officer | 27. September 2024 A | 250.000 | 0 | 0 | $0 |
| Christine Chambers | CFO | 31. Mai 2024 D | 65.146 | 0 | 0 | $0 |
| Bruce S Rosenbloom | Chief Financial Officer | 30. Juli 2021 A | 45.450 | 0 | 0 | $0 |
| Tamar Elkeles | Direktor | 17. September 2026 A | 49.923 | 0 | 0 | $0 |
| Peter Batushansky | Direktor | 11. August 2026 A | 91.928 | 0 | 0 | $0 |
| Justin L. Mennen | Direktor | 11. August 2026 A | 98.274 | 0 | 0 | $0 |
| Gian Fulgoni | Direktor | 21. Januar 2026 D | 132.299 | 0 | 0 | $0 |
| Leah Solivan | Direktor | 30. Oktober 2025 A | 42.289 | 0 | 0 | $0 |
| Diana G Purcel | Direktor | 8. August 2024 A | 24.375 | 0 | 0 | $0 |
| Jodi Watson | Direktor | 28. Juli 2022 A | 18.880 | 0 | 0 | $0 |
| Peter Cobb | Direktor | 28. Juli 2022 A | 15.000 | 0 | 0 | $0 |
| Ronald J Korn | Direktor | 30. Juli 2021 A | 90.833 | 0 | 0 | $0 |
| Frank J Formica | Direktor | 29. Januar 2021 S | 55.000 | 0 | 0 | $0 |
| Robert C Schweitzer | Direktor | 28. August 2020 S | 95.834 | 0 | 0 | $0 |
| Marc Puleo MD | Direktor | 16. August 2005 J | 913.286 | 0 | 0 | $0 |
| SilverCape Investments Limited | 10%-Eigentümer | 13. August 2025 P | 2.579.696 | 0 | 0 | $0 |
| TRICON HOLDINGS LLC | 10%-Eigentümer | 4. August 2006 S | 2.284.000 | 0 | 0 | $0 |
| James Lacamp | · | 11. August 2026 A | 90.421 | 0 | 0 | $0 |
| Jacqueline Paula Smith | · | 15. Januar 2025 A | 28.099 | 0 | 0 | $0 |
| Mathew N Hulett | · | 29. April 2024 D | 103.850 | 0 | 0 | $0 |
| Mark Bradley Moseley JR | · | 11. Dezember 2023 A | 42.000 | 0 | 0 | $0 |
| Daniel Job Pingree | · | 17. Mai 2023 A | 22.000 | 0 | 0 | $0 |
| CRESLIN LTD | · | 4. August 2006 S | 2.284.000 | 0 | 0 | $0 |
| Guven Kivilcim | · | 22. Januar 2004 S | 1.310.300 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 20 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| EWUS · iShares Trust | 0,25% | 37.222 SH | 11. September 2026 | Täglich |
| ISVL · iShares Trust | 0,17% | 202.554 SH | 11. September 2026 | Täglich |
| ISCF · iShares Trust | 0,09% | 216.018 SH | 11. September 2026 | Täglich |
| IEUS · iShares Trust | 0,07% | 45.419 SH | 11. September 2026 | Täglich |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,05% | 58.613 SH | 2. Oktober 2026 | Täglich |
| SCZ · iShares Trust | 0,03% | 1.496.647 SH | 11. September 2026 | Täglich |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 1.566.925 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 26.193 SH | 11. September 2026 | Täglich |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 1.056.528 SH | 19. August 2026 | Täglich |
| IEUR · iShares Trust | 0,01% | 291.699 SH | 11. September 2026 | Täglich |
| IWC · iShares Trust | 0,01% | 51.213 SH | 11. September 2026 | Täglich |
| IEFA · iShares Trust | 0,00% | 3.372.753 SH | 11. September 2026 | Täglich |
| IDEV · iShares Trust | 0,00% | 546.389 SH | 11. September 2026 | Täglich |
| IXUS · iShares Trust | 0,00% | 684.652 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 211.088 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 602.795 SH | 19. August 2026 | Täglich |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 6.557.275 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 341.189 SH | 19. August 2026 | Täglich |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 4.366.658 SH | 19. August 2026 | Täglich |
| VSGX · VANGUARD WORLD FUND | 0,00% | 78.854 SH | 19. August 2026 | Täglich |
PETS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
12-Monats-Kursziel
1 Analysten · 2026-10-01Mittelwert-Ziel $1.40 +2,9%
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PETS | $49M | -0.8 | -21.1% | -32.0% | -100.4% | 28.1% |
| RENT | · | 3.7 | 7.7% | 6.9% | -16.9% | · |
| GROV | $46M | -3.2 | -14.6% | -6.7% | 75.6% | 53.7% |
| SPWH | $52M | -1.1 | 0.96% | -4.1% | -25.2% | 30.9% |
| LESL | $46M | -0.2 | -6.6% | -19.1% | 70.0% | 35.4% |
| ULTA | $27.83B | 24.6 | 9.7% | 9.3% | 42.7% | 39.1% |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.